DirectorsTalk Interviews brings investors closer to the people behind listed companies, markets and sectors. We feature interviews with CEOs from UK, US and Canadian companies, alongside fund managers, analysts and sector specialists, giving audiences direct insight into strategy, performance, opportunities and risks. Each interview is designed to help investors understand the businesses shaping the market and make more informed decisions.
City of London Investment Group (LON:CLIG) is the topic of conversation when Brian Moretta, Analyst at Hardman & Co joins DirectorsTalk Interviews. Brian talks us through the main points from..
Strix Group Plc (LON:KETL) CEO Mark Bartlett joins DirectorsTalk Interviews to discuss preliminary results for the twelve months ended 31 December 2022. Mark takes us through the financial highlights, explains..
Oakley Capital Investments (LON:OCI) is the topic of conversation when Mark Thomas joins DirectorsTalk Interviews. Mark gives us an overview of his report entitled ‘2022: NAV returns driven by EBITDA..
Nuformix plc (LON:NFX) Executive Director Dan Gooding joins DirectorsTalk to discuss an update on its NXP002 study results. Dan is delighted to remind us of what the NXP002 programme is..
Concurrent Technologies Plc (LON:CNC) Strategy Director Nigel Forrester joins DirectorsTalk Interviews to discuss the launch of Hermes, a high-performance Plug In Card based on an Intel® processor. Nigel provides a..
H&T Group Plc (LON:HAT) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark talks us through is recent report on the company..
Avation PLC (LON:AVAP) Executive Chairman Jeff Chatfield joins DirectorsTalk Interviews to tell us more about the company. With the Company’s future strategy focusing on leasing modern, low CO2 emissions and..
Eden Research Plc (LON:EDEN) CEO Sean Smith joins DirectorsTalk Interviews to discuss regulatory approval for its formulated products Mevalone® and Cedroz™. Sean explains why they need ‘state approval’ when it..
Zotefoams plc (LON:ZTF) Chief Executive Officer David Stirling joins DirectorsTalk Interviews to discuss preliminary results (unaudited) for the year ended 31 December 2022. David talks us through the financial highlights,..
Saietta Group Plc (LON:SED) Executive Chairman Tony Gott joins DirectorsTalk Interviews to discuss a collaboration with AVTEC. Tony explains the various synergies that working with AVTEC will bring to Saietta,..
Boku Inc. (LON:BOKU) Chief Executive Officer Jon Prideaux joins DirectorsTalk Interviews to discuss audited results for the year ended 31 December 2022. Jon takes us through the results highlights, explains..
Apax Global Alpha (LON:APAX) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark talks us through his recent report entitled ‘Outperformance by..
Baron Oil Plc (LON:BOIL) CEO Andy Yeo joins DirectorsTalk Interviews to discuss a competent persons report for the Chuditch asset in Timor Leste. Andy shares his thoughts on the report,..
Dekel Agri-vision (LON:DKL) Executive Director Lincoln Moore joins DirectorsTalk Interviews to discuss a February production update and an update on progress regarding the ramp up of production for the large..
Miton UK MicroCap Trust (LON:MINI) Co fund manager Gervais William joins DirectorsTalk Interviews to discuss the effects of Jeremy Hunt’s Spring budget on investing. Gervais explains what stood out in..
Pantheon International Plc (LON:PIN) is the topic of conversation when Mark Thomas, Analyst at Hardman & Co joins DirectorsTalk Interviews. Mark talks us through his note entitled “Exceptional companies, long-term..
Accrol Group Holdings Plc (LON:ACRL) CEO Gareth Jenkins joins DirectorsTalk Interviews to discuss an agreement with one of the world’s largest consumer goods companies Unilever plc (LON:ULVR). Gareth explains what..
Fidelity European Trust (LON:FEV) is the topic of conversation when Riccardo Bindi, Analyst at Hardman & Co joins DirectorsTalk Interviews. Riccardo gives us an overview of his note entitled ‘A..
N4 Pharma plc (LON:N4P) CEO Nigel Theobald joins DirectorsTalk Interviews to discuss results for the year ended 31 December 2022. Nigel explains how the market for N4 Pharma has changed..
Spiritus Mundi Plc (LON:SPMU) Consultant Kon Gryllakis joins DirectorsTalk Interviews to discuss why he joined the company as a strategic consultant. Kon provides us with his background details, how his..
